- Home
- NVVE vs PBM Comparison
NVVE vs PBM Comparison
Compare NVVE & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- PBM
- Stock Information
- Founded
- NVVE 1996
- PBM 1994
- Country
- NVVE United States
- PBM Canada
- Employees
- NVVE N/A
- PBM N/A
- Industry
- NVVE Oil Refining/Marketing
- PBM
- Sector
- NVVE Energy
- PBM
- Exchange
- NVVE Nasdaq
- PBM NYSE
- Market Cap
- NVVE 2.8M
- PBM 2.8M
- IPO Year
- NVVE N/A
- PBM N/A
- Fundamental
- Price
- NVVE $2.82
- PBM $1.53
- Analyst Decision
- NVVE
- PBM
- Analyst Count
- NVVE 0
- PBM 0
- Target Price
- NVVE N/A
- PBM N/A
- AVG Volume (30 Days)
- NVVE 11.5K
- PBM 2.2M
- Earning Date
- NVVE 11-12-2024
- PBM 02-02-2025
- Dividend Yield
- NVVE N/A
- PBM N/A
- EPS Growth
- NVVE N/A
- PBM N/A
- EPS
- NVVE N/A
- PBM N/A
- Revenue
- NVVE $5,144,831.00
- PBM N/A
- Revenue This Year
- NVVE $200.61
- PBM N/A
- Revenue Next Year
- NVVE $109.43
- PBM N/A
- P/E Ratio
- NVVE N/A
- PBM N/A
- Revenue Growth
- NVVE N/A
- PBM N/A
- 52 Week Low
- NVVE $2.82
- PBM $1.51
- 52 Week High
- NVVE $72.70
- PBM $945.15
- Technical
- Relative Strength Index (RSI)
- NVVE 30.04
- PBM 20.19
- Support Level
- NVVE $3.31
- PBM $1.85
- Resistance Level
- NVVE $3.69
- PBM $2.11
- Average True Range (ATR)
- NVVE 0.22
- PBM 0.55
- MACD
- NVVE -0.05
- PBM 0.07
- Stochastic Oscillator
- NVVE 0.00
- PBM 0.80
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.